OrthoPediatrics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was USD 111.12 million compared to USD 91.3 million a year ago. Net loss was USD 14.28 million compared to net income of USD 9.11 million a year ago. Basic loss per share from continuing operations was USD 0.63 compared to basic earnings per share from continuing operations of USD 0.44 a year ago. Diluted loss per share from continuing operations was USD 0.63 compared to diluted earnings per share from continuing operations of USD 0.43 a year ago.